Prudential Financial
CRBU icon

Prudential Financial’s Caribou Biosciences CRBU Stock Holding History

Prudential Financial’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.5K Buy
34,375
+15,375
+81% +$30.4K ﹤0.01% 2396
2026
Q1 		$36.1K Buy
+19,000
New +$32.6K ﹤0.01% 2345
2025
Q3 		– Sell
-10,600
Closed -$13.4K – 2445
2025
Q2 		$13.4K Buy
+10,600
New +$10.4K ﹤0.01% 2415
2025
Q1 		– Sell
-20,772
Closed -$33K – 2309
2024
Q4 		$33K Sell
20,772
-111,100
-84% -$223K ﹤0.01% 2246
2024
Q3 		$258K Sell
131,872
-3,617
-3% -$7.41K ﹤0.01% 2441
2024
Q2 		$222K Buy
135,489
+53,871
+66% +$172K ﹤0.01% 2455
2024
Q1 		$420K Buy
81,618
+66,694
+447% +$411K ﹤0.01% 2227
2023
Q4 		$85.5K Buy
14,924
+2,314
+18% +$11.4K ﹤0.01% 2513
2023
Q3 		$60.3K Sell
12,610
-55,814
-82% -$346K ﹤0.01% 2482
2023
Q2 		$291K Buy
+68,424
New +$307K ﹤0.01% 2307

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Prudential Financial's CRBU Position: Q2 2026 in Review

Prudential Financial increased its Caribou Biosciences (CRBU) stake by 81% in Q2 2026, buying an estimated $30.4K and bringing the position to 34,375 shares worth $60.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2396.

Prudential Financial first reported a position in CRBU in Q2 2023 and has held it in 10 quarters since. The position peaked at $420K in Q1 2024. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Prudential Financial held 34,375 shares of Caribou Biosciences worth $60.5K as of Q2 2026.
  • Prudential Financial bought 15,375 Caribou Biosciences shares in Q2 2026, an estimated $30.4K.
  • Caribou Biosciences made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2396 holding.
  • Prudential Financial first reported a position in Caribou Biosciences in Q2 2023 and has held it in 10 quarters since.
  • Prudential Financial's Caribou Biosciences position peaked at $420K in Q1 2024.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.